An international audience of more than 4000 health professionals and researchers from around the world will meet today for the opening of the European Congress on Osteoporosis & Osteoarthritis (IOF-ECCEO12) in Bordeaux, France.
As a joint Congress of the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), IOF-ECCEO12 is the most noteworthy annual bone event in Europe. The congress will showcase the latest clinical research in close to 700 abstracts, presented in oral and poster sessions. In addition, the Congress hosts the IOF-ESCEO 2nd Pre-Clinical Symposium, a forum dedicated to translational bone research.
Professor John A. Kanis, IOF President and Co-Chair of the congress, stated "We're exceptionally pleased to welcome a broad spectrum of delegates from close to 100 countries. The Scientific Programme Committee, headed by Professors Cyrus Cooper and René Rizzoli, has organized an outstanding agenda of plenaries and sessions. Delegates can look forward to three days of stimulating discussion and exciting new science presented by the world's leading investigators."
The broad scientific programme comprises 8 plenary sessions, 12 Meet the Expert sessions, 40 oral presentations of selected abstracts, 10 special topical symposia and 6 satellite symposia. With up to 18 CME credits awarded, the Congress offers delegates valuable strategies to treat patients more effectively in their daily clinical practice.
ESCEO President and Congress Co-Chair Professor Jean-Yves Reginster commented, "It is vitally important that health professionals in Europe and around the world learn about the latest clinical advances and research findings in the prevention, diagnosis and treatment of osteoporosis and osteoarthritis. These musculoskeletal diseases pose an enormous social and health-economic burden, causing disability and loss of quality of life in millions of sufferers. It is our hope that this annual congress will arm clinicians with the information they need to prevent these diseases and provide the best possible care to their patients."
The European Congress on Osteoporosis & Osteoarthritis continues at Bordeaux's Palais des Congrès until the 24th of March. Congress abstracts are published in the journal Osteoporosis International Volume 23, Supplement 2, 2012.
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization devoted to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members – including committees of scientific researchers, patient, medical and research societies, and industry representatives from around the globe - share a common vision of a bone healthy future without fragility fractures. IOF now represents more than 200 societies in all regions of the world. http://www.iofbonehealth.org
The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost- conscious perception. http://www.esceo.org
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.